Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Generic Sponsors Need To Increase Communications About Drug Master Files, US FDA Says

Aug 25 2017

• By Derrick Gingery

FDA entrance sign 2016

Related Content

FDARA Takes Effect With Under-The-Radar Presidential Signature

Aug 19 2017

ANDA Sponsors Get Wide-Open Facility Deadline For Priority Review

Aug 23 2017

ANDA Sponsors May Need Extra Three Months To Avoid DMF-Related Delays

Oct 15 2012

Deficient DMFs Jeopardizing Timely Approvals of ANDAs

Jun 05 2017

ANDAs Can Get Priority, Eight-Month Reviews Under User Fee Deal

Sep 24 2016

GDUFA II: ANDAs, Not Facilities Will Govern Revenue

Sep 26 2016

Additional Topics

United States Generic Drugs Review Pathway Regulation FDA BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window